Thalassaemia major manifests in-
So, the core concept would be the pathophysiology of Thalassaemia major. It's an autosomal recessive disorder with mutations in the alpha or beta globin genes. The major type usually refers to beta-thalassaemia major, which causes severe anemia due to reduced beta-globin chains, leading to excess alpha chains that precipitate and damage red blood cells.
Now, the correct answer is likely about the clinical presentation. Thalassaemia major typically presents in early childhood, around 2 years of age. So the options might include age of onset, symptoms like anemia, or complications. The user's correct answer is missing, but common options could be A. Neonatal period, B. Infancy, C. Adolescence, D. Adulthood. So the correct answer would be B. Infancy, as that's when symptoms become apparent.
For the wrong options: A. Neonatal period is incorrect because symptoms don't show at birth due to fetal hemoglobin. C and D are later stages, but major thalassemia is severe and presents early.
Clinical pearl: Remember that beta-thalassaemia major presents in early childhood, requiring regular transfusions. Distinguishing from other anemias is key.
Now, structuring the explanation with the required sections. Need to make sure all parts are covered concisely, using medical terms. Check for character count to stay within 2500. Also, ensure each section is properly labeled and the correct answer is highlighted at the end. Let me put it all together now.
**Core Concept**
Thalassaemia major is an *autosomal recessive hemoglobinopathy* caused by mutations in the *beta-globin gene (HBB)*, leading to impaired synthesis of beta-globin chains. This results in *ineffective erythropoiesis*, *hemolytic anemia*, and *excess alpha-globin chain accumulation*, which precipitate and damage red blood cells.
**Why the Correct Answer is Right**
Thalassaemia major typically presents in **early childhood** (usually by age 2) due to severe *hypochromic microcytic anemia*. The lack of functional beta-chains disrupts hemoglobin A (Ξ±2Ξ²2) production, causing erythroid precursors to die prematurely (ineffective erythropoiesis). Surviving red blood cells are fragile and hemolyzed, worsening anemia. Clinical features include growth retardation, hepatosplenomegaly, and skeletal changes from expanded bone marrow.
**Why Each Wrong Option is Incorrect**
**Option A:** Neonatal period (birth to 1 month) is incorrect because fetal hemoglobin (Ξ³-globin) compensates for beta-chain deficiency during gestation. Symptoms emerge after 6 months when Ξ²-globin becomes essential.
**Option C:** Adolescence/adulthood is incorrect; thalassaemia major is a severe form requiring lifelong management. Delayed presentation suggests milder variants (e.g., th